Progesterone Suppliers & Bulk Manufacturers
Available Forms: Vaginal gel
Available Strengths: 4% and 8%
Reference Brands: Crinone® (US & EU), Prochieve®(EU)
Category:
Women's Health
Progesterone Gel is widely used in the US and EU for women’s health, especially in fertility treatments and HRT. Available in 4% and 8% strengths, it provides effective luteal phase support with fewer systemic side effects. Marketed as Crinone® and Prochieve®, it is trusted by fertility clinics and pharmacies.
Progesterone is available in Vaginal gel
and strengths such as 4% and 8%.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Progesterone is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Progesterone can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Progesterone Gel is a clinically trusted hormone therapy product widely used in the US and EU for women’s health, particularly in assisted reproductive technology (ART) and hormone replacement therapy (HRT). Marketed under brand names like Crinone® and Prochieve® in the US, and Crinone® in the EU, it delivers bioidentical progesterone directly to the uterus via vaginal application. Available in 4% and 8% strengths, the gel ensures effective luteal phase support with minimal systemic side effects. In the pharmaceutical B2B sector, progesterone gel is in high demand by fertility centers, clinics, and specialty pharmacies across regulated international markets.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing